InsidersTradesSigma
Browse the detailed record of transactions filed by Dudley Robert Michael, 首席执行官. Director active across 1 company, notably Transcode Therapeutics, Inc.. Aggregated, 1 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €48k. History available since 27 May 2022. The latest transaction was filed on 27 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Robert Michael Dudley is the Chief Executive Officer of Transcode Therapeutics, Inc. He oversees the company's operations and is responsible for implementing the development strategy. His expertise in the biopharmaceutical field enables him to lead innovative projects and promote research and development.